Pharmaceutical companies established in 1997

Actelion Pharmaceuticals Ltd. is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland. The company is part of Johnson & Johnson Innovative Medicine business segment.

Merial was a multinational animal health company in Lyon, France. It was founded in 1997 as a joint venture between Merck & Co. and Sanofi-Aventis. In January 2017, Merial was acquired by Boehringer Ingelheim and merged with Boehringer Ingelheim's existing animal health assets.

Chinese pharmaceutical company

American company

Irish tax-registered pharmaceutical

Seagen Inc. (formerly Seattle Genetics, Inc.) is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington (a suburb of Seattle), was considered the industry leader in antibody-drug conjugates or ADCs, a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells, with its development of drugs such as Adcetris, Padcev, and Tivdak. Antibody-drug conjugates are intended